510(k) K031016

Device
FREELITE HUMAN KAPPA AND LAMBDA FREE KITS FOR USE ON THE DAD BEHRING NEPHELOMETER II
Applicant
THE BINDING SITE, LTD.
510(k) number
K031016
Product code
DEH  
Decision
Substantially Equivalent (SESE)
Decision date
2003-07-15
Date received
2003-03-31
Regulation
866.5550
Classification name
Lambda, Antigen, Antiserum, Control
Medical specialty
Immunology
Review panel
Immunology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
JAY H GELLER
Address
West Tower, Suite 4000 2425 W. Olympic Blvd. Santa Monica CA US 90404 90404

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code DEH  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K172471VENTANA CD30 (Ber-H2) RxDx AssayVentana Medical Systems, Inc.2018-05-08
K140396FREELITE HUMAN LAMBDA FREE KITThe Binding Site Group , Ltd.2014-04-16
K083601LAMBDA LIGHT CHAINSSENTINEL CH. SpA2009-06-22
K033811FREELITE HUMAN KAPPA AND LAMBDA FREE KITS FOR USE ON THE OLYMPUS AU ANALYZERThe Binding Site, Ltd.2004-01-30
K023131FREELITE HUMAN LAMBDA FREE KITThe Binding Site, Ltd.2003-01-21
K010440FREELITE LAMBDA FREE KITThe Binding Site, Ltd.2001-04-26
K010441FREELITE KAPPA FREE KITThe Binding Site, Ltd.2001-04-26
K003671LAMBDA IMMAGE FREELITE KITThe Binding Site, Ltd.2001-02-01
K002563SHEEP ANTI-HUMAN LAMBDA FREE LIGHT CHAIN IMMUNOFIXATION GRADE KITThe Binding Site, Ltd.2000-10-26
K971905DAKO MOUSE ANTI HUMAN CYTOKERATIN, HIGH MOLECULAR WEIGHT, CLONE 34BE12, MONOCLONAL ANTIBODY FOR IMMUNOENZYMATIC STAININGDako Corp.1997-12-12
K965022MONOCLONAL MOUSE ANTI-HUMAN CD30, KI-1 ANTIGEN, BER-H2 ANTIBODY FOR IMMUNOENZYMATIC STAINING (PRODUCT CODE NO. MO751)Dako Corp.1997-11-06
K940583VENTANA CD45 PRIMARY ANTIBODYVentana Medical Systems, Inc.1997-10-20
K973393CHEMMATE LCAVentana Medical Systems, Inc.1997-09-25
K941514VENTANA ANTI-S100 PRIMARY ANTIBODYVentana Medical Systems, Inc.1997-04-25
K941170VENTANA ANTI-MELANOMA PRIMARY ANTIBODYVentana Medical Systems, Inc.1997-04-22

Legacy Summary#

summary

FDA Review#

Decision Summary